MedPath

成都天台山制药股份有限公司

Ownership
-
Established
2000-09-29
Employees
-
Market Cap
-
Website
www.cdttszy.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

183

NMPA:183

Drug Approvals

Pentoxifylline Injection

Product Name
己酮可可碱注射液
Approval Number
国药准字H20254040
Approval Date
Apr 30, 2025
NMPA

Naloxone Hydrochloride Injection

Product Name
盐酸纳洛酮注射液
Approval Number
国药准字H20258030
Approval Date
Mar 13, 2025
NMPA

Phloroglucinol Injection

Product Name
间苯三酚注射液
Approval Number
国药准字H20249798
Approval Date
Dec 25, 2024
NMPA

Thioctic Acid Injection

Product Name
硫辛酸注射液
Approval Number
国药准字H20244904
Approval Date
Sep 19, 2024
NMPA

Chondroitin Sulfate Sodium Capsules

Product Name
硫酸软骨素钠胶囊
Approval Number
国药准字H51023415
Approval Date
Jun 14, 2024
NMPA

Moxifloxacin Hydrochloride Injection

Product Name
盐酸莫西沙星注射液
Approval Number
国药准字H20140125
Approval Date
Jun 14, 2024
NMPA

Chondroitin Sulfate Sodium Tablets

Product Name
硫酸软骨素钠片
Approval Number
国药准字H51022917
Approval Date
Jun 14, 2024
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H51023122
Approval Date
Apr 24, 2024
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H51022702
Approval Date
Apr 24, 2024
NMPA

Adenosine Disodium Triphosphate Tablets

Product Name
三磷酸腺苷二钠片
Approval Number
国药准字H51023417
Approval Date
Apr 24, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 19
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.